Skip to Main Content

Paper Details

Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Acta Neuropathol
42
2021
Author NameAffiliation
Pascal D JohannSwabian Childrens' Cancer Center Augsburg
Pascal D JohannGerman Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK)
Pascal D JohannHopp Children's Cancer Center (KiTZ)
Michael BockmayrUniversity Medical Center Hamburg-Eppendorf
Michael BockmayrResearch Institute Children's Cancer Center Hamburg
Michael BockmayrInstitute of Pathology, Corporate Member of Freie Universitat Berlin, Universitatsmedizin Berlin, Humboldt-Universitat Zu Berlin and Berlin Institute of Health
Julien Masliah-PlanchonINSERM U, SIREDO Pediatric Oncology Center, Curie Institute
Mamy AndrianteranagnaINSERM U, SIREDO Pediatric Oncology Center, Curie Institute
Mamy AndrianteranagnaINSERM U, PSL Research University, Curie Institute
Franck BourdeautINSERM U, SIREDO Pediatric Oncology Center, Curie Institute
Franck BourdeautCurie Institute
Annie HuangINSERM U, SIREDO Pediatric Oncology Center, Curie Institute
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK)
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Anne BendelChildren's Hospitals and Clinics of Minnesota
William D FoulkesMcGill University
William D FoulkesMcGill University
Michael C FrühwaldSwabian Childrens' Cancer Center Augsburg
Ulrich Sch??llerUniversity Medical Center Hamburg-Eppendorf
Ulrich Sch??llerResearch Institute Children's Cancer Center Hamburg
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf
  • 1 - 25

Datasets